Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio

Avobis Bio's AVB-114 implantable cell therapy granted US FDA RMAT designation for Crohn's perianal fistulas

Celltrion launches AVTOZMA IV in the United States following FDA approval

Novartis to launch US direct-to-patient platform for Cosentyx

Vascarta completes VAS-101 osteoarthritis clinical trial

Sen-Jam Pharmaceutical and KVK Tech complete final development deliverables for SJP-002C

OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University

ResVita Bio completes face-to-face Pre-IND meeting with FDA for RVB-003

Dr Eric Berg Joins Forces with Robert F. Kennedy Jr. to Advocate for Transparency in Vaccine Science and Public Health

N4 Pharma advances RNA delivery breakthrough with SRI collaboration

EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi

Sanofi and Regeneron's Dupixent receives positive CHMP opinion for chronic spontaneous urticaria in EU

Evommune reveals further positive data from Phase 2 EVO756 trial

J & D Pharmaceuticals receives Orphan Drug Designation for JD-004

Ascletis presents Phase III results of denifanstat (ASC40) for acne treatment at EADV Congress 2025